Effect of APOE &egr; Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis
暂无分享,去创建一个
[1] Michael J.A. Williams,et al. Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a) , 2017, Circulation research.
[2] S. Tsimikas,et al. Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[3] B. Nordestgaard,et al. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology , 2016, Journal of Lipid Research.
[4] Jacqueline P Mitchell,et al. Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies , 2016, PLoS medicine.
[5] B. Nordestgaard,et al. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study. , 2016, The lancet. Diabetes & endocrinology.
[6] B. Nordestgaard,et al. PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis. , 2016, The Journal of clinical endocrinology and metabolism.
[7] F. Kronenberg,et al. Structure, function, and genetics of lipoprotein (a) , 2016, Journal of Lipid Research.
[8] B. Nordestgaard,et al. Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population. , 2016, Atherosclerosis.
[9] William Valdar,et al. Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study , 2015, Journal of Human Genetics.
[10] B. Nordestgaard,et al. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population. , 2015, The Journal of clinical endocrinology and metabolism.
[11] B. Nordestgaard,et al. Plasma levels of apolipoprotein E and risk of dementia in the general population , 2015, Annals of neurology.
[12] B. Nordestgaard,et al. Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. , 2014, Atherosclerosis.
[13] Tom R. Gaunt,et al. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. , 2013, International journal of epidemiology.
[14] Kathleen F. Kerr,et al. Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.
[15] M. Okubo,et al. Lipoprotein(a)-cholesterol: a significant component of serum cholesterol. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[16] R. Collins,et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.
[17] Børge G Nordestgaard,et al. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. , 2009, JAMA.
[18] Bernard Keavney,et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. , 2007, JAMA.
[19] B. Nordestgaard,et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. , 2007, JAMA.
[20] T. Pearson,et al. ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Studys⃞ Published, JLR Papers in Press, December 15, 2006. , 2007, Journal of Lipid Research.
[21] M. Krempf,et al. Influence of Atorvastatin on Apolipoprotein E and AI Kinetics in Patients with Type 2 Diabetes , 2005, Journal of Pharmacology and Experimental Therapeutics.
[22] S. Humphries,et al. Apolipoprotein E phenotype and lipoprotein(a) in familial hypercholesterolaemia implication for lipoprotein(a) metabolism , 1994, The clinical investigator.
[23] L. Bernier,et al. Effect of Atorvastatin on ApoE and ApoC-I Synthesis and Secretion by THP-1 Macrophages , 2003, Journal of cardiovascular pharmacology.
[24] H. Hobbs,et al. Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures. , 2001, Journal of lipid research.
[25] P. Schnohr,et al. Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. , 2000, Journal of lipid research.
[26] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[27] R. Mahley,et al. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. , 1999, Current opinion in lipidology.
[28] R. Mahley,et al. Hypolipidemic and Hyperlipidemic Phenotypes in Transgenic Mice Expressing Human Apolipoprotein E2* , 1996, Journal of Biological Chemistry.
[29] O. Faergeman,et al. Effects of apoE gene polymorphism on Lp(a) concentrations depend on the size of apo(a): a study of 466 white men , 1996, Journal of Molecular Medicine.
[30] R. Lanford,et al. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. , 1994, The Journal of biological chemistry.
[31] D. Rader,et al. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. , 1994, The Journal of clinical investigation.
[32] A. Kondo,et al. Effects of apolipoprotein E polymorphism on plasma lipoprotein(a) levels. , 1993, Artery.
[33] P. de Knijff,et al. Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a). , 1991, Atherosclerosis.